The Foundations for Single-Use Manufacturing. Redefined from A – Z. introduced by Stefan Schlack, Head of Marketing Bioprocess Solutions Edit

In 2017, the BioPhorum Operations Group, or BPOG for short, published the Biomanufacturing Technology Roadmap. They identified four market trends that are likely to lead to major changes in the biopharmaceutical industry: Continued market growth, arrival of new product classes, uncertainty in product success and sales as well as cost pressure. BPOG concluded that a step-change in business performance must occur. They identified quality, cost, flexibility and speed as critical success factors for the future. Single-use technologies will help to overcome these challenges. In the past, biopharma companies were struggling with various risks factors which kept them from implementing single-use solutions. With our solid single-use foundation for biomanufacturing processes we are solving all of these challenges simultaneously. Our fully integrated single-use platform connects an exclusive approach in biocompatibility, state-of-the-art integrity control and testing as well as a unique automation platform and supply network. This strategy provides flexibility and acceleration which leads to a cost-effective process and ensure the quality of your biologics and enhance patient safety. This demonstrates how we are building the foundations for end-to-end single-use manufacturing.